Compare TAYD & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAYD | STIM |
|---|---|---|
| Founded | 1955 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.1M | 136.3M |
| IPO Year | N/A | 2018 |
| Metric | TAYD | STIM |
|---|---|---|
| Price | $48.81 | $1.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 4.7K | ★ 2.1M |
| Earning Date | 01-02-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.72 | N/A |
| Revenue | $44,593,219.00 | ★ $129,873,000.00 |
| Revenue This Year | $10.81 | $101.67 |
| Revenue Next Year | $8.37 | $10.87 |
| P/E Ratio | $17.48 | ★ N/A |
| Revenue Growth | N/A | ★ 78.61 |
| 52 Week Low | $29.50 | $1.00 |
| 52 Week High | $53.73 | $5.92 |
| Indicator | TAYD | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 51.56 | 30.82 |
| Support Level | $47.74 | $1.28 |
| Resistance Level | $50.56 | $1.51 |
| Average True Range (ATR) | 1.33 | 0.18 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 58.94 | 12.82 |
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.